BR0215682A - Lactoferrina - Google Patents

Lactoferrina

Info

Publication number
BR0215682A
BR0215682A BR0215682-2A BR0215682A BR0215682A BR 0215682 A BR0215682 A BR 0215682A BR 0215682 A BR0215682 A BR 0215682A BR 0215682 A BR0215682 A BR 0215682A
Authority
BR
Brazil
Prior art keywords
polypeptide
lactoferrin
mixture
fragment
treating
Prior art date
Application number
BR0215682-2A
Other languages
English (en)
Inventor
Jillian Cornish
Ian Reginald Reid
Kay Patricia Palmano
Neil Ward Haggarty
Original Assignee
Fonterra Res Ct Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fonterra Res Ct Ltd filed Critical Fonterra Res Ct Ltd
Publication of BR0215682A publication Critical patent/BR0215682A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)

Abstract

"LACTOFERRINA". Polipeptídio do tipo lactoferrina pura contendo não mais que dois íons metálicos por molécula, ou uma mistura do polipeptídio e um fragmento do mesmo. O polipeptídio ou a mistura estimula o crescimento esqueletal e inibe a reabsorção óssea. Também está descrito um método para tratamento de um distúrbio ósseo com o polipeptídio ou com a mistura.
BR0215682-2A 2002-04-03 2002-07-29 Lactoferrina BR0215682A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ51812102 2002-04-03
PCT/NZ2002/000137 WO2003082921A1 (en) 2002-04-03 2002-07-29 Lactoferrin

Publications (1)

Publication Number Publication Date
BR0215682A true BR0215682A (pt) 2005-01-04

Family

ID=28673156

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0215682-2A BR0215682A (pt) 2002-04-03 2002-07-29 Lactoferrina

Country Status (14)

Country Link
US (5) US20030191193A1 (pt)
EP (1) EP1490404B1 (pt)
JP (1) JP4327607B2 (pt)
KR (1) KR20050006140A (pt)
CN (1) CN1625566B (pt)
AR (1) AR040695A1 (pt)
AU (1) AU2002324387A1 (pt)
BR (1) BR0215682A (pt)
CA (1) CA2481315A1 (pt)
DK (1) DK1490404T3 (pt)
ES (1) ES2435071T3 (pt)
HK (1) HK1074635A1 (pt)
PT (1) PT1490404E (pt)
WO (1) WO2003082921A1 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030191193A1 (en) * 2002-04-03 2003-10-09 Jillian Cornish Lactoferrin
EP1576964A4 (en) * 2002-11-29 2008-06-11 Morinaga Milk Industry Co Ltd PROTEASE INHIBITOR
US7956031B2 (en) 2005-05-31 2011-06-07 Naidu Lp Metallo-lactoferrin-coenzyme compositions for trigger and release of bioenergy
TWI276442B (en) * 2005-07-05 2007-03-21 Maxluck Biotechnology Corp Composition of controlling and preventing heart disease
AU2006300009A1 (en) * 2005-10-14 2007-04-19 Auckland Uniservices Limited Use of lactoferrin fragments and hydrolysates
EP1952818A4 (en) * 2005-10-27 2009-10-21 Sunstar Inc OSTEOCLASTICIZATION PREPARATION, ORAL AGGREGATION AND PROPHYLACTIC OR THERAPEUTIC AGENT AGAINST BONE DISEASES WITH LACTOFERRIN-CONTAINING LIPOSOME
US8021659B2 (en) 2006-04-28 2011-09-20 Naidu Lp Coenzyme Q10, lactoferrin and angiogenin compositions and uses thereof
FR2903906B1 (fr) * 2006-07-19 2010-11-05 Bio Serae Laboratoires Composition pour prevenir et/ou traiter les maladies articulaires degeneratives.
WO2008094493A2 (en) * 2007-01-26 2008-08-07 Ventria Bioscience Compositions containing lactoferrin and calcium, and methods of using same
JP2008303168A (ja) * 2007-06-07 2008-12-18 Japan Health Science Foundation 破骨細胞制御剤とそのスクリーニング方法
NZ583234A (en) 2007-07-10 2012-06-29 Glanbia Nutritionals Method for removing endotoxin from proteins
US8614189B2 (en) * 2008-09-24 2013-12-24 University Of Connecticut Carbon nanotube composite scaffolds for bone tissue engineering
US9737575B2 (en) 2008-11-28 2017-08-22 University Of Otago Use of lactic acid bacteria to treat or prevent eczema
FR2950510B1 (fr) * 2009-09-28 2013-04-12 Groupe Lactalis Derive laitier pour son utilisation dans le developpement et/ou le maintien de la condition physique des mammiferes, en particulier des animaux de competition.
AU2011251991B2 (en) * 2010-05-10 2014-05-22 University Of Connecticut Lactoferrin -based biomaterials for tissue regeneration and drug delivery
US20160166638A1 (en) * 2013-07-05 2016-06-16 Nestec S.A. Lactoferrin-osteopontin-iron complex
US10018418B2 (en) 2014-01-07 2018-07-10 Can-Eng Partners Limited Mobile removable hearth for furnace and transporter
EP4136985A1 (en) 2016-12-22 2023-02-22 University of Otago Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus
US11395839B2 (en) 2016-12-22 2022-07-26 University Of Otago Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4073A (en) * 1845-06-07 Machine fob
US154032A (en) * 1874-08-11 Improvement in processes of preparing glass
FR884786A (fr) * 1942-04-03 1943-08-26 Comp Generale Electricite Sortie isolante pour câble électrique soumis à de hautes pressions
JPH0621077B2 (ja) * 1986-07-15 1994-03-23 雪印乳業株式会社 造血剤
JP2564185B2 (ja) * 1988-10-11 1996-12-18 森永乳業株式会社 生物活性組成物
DE69002024T2 (de) * 1989-02-25 1993-11-18 Morinaga Milk Industry Co Ltd Bioaktive Laktoferrin Derivate.
EP0426924A1 (en) 1989-11-09 1991-05-15 Cellena (Cell Engineering) A.G. Production of metal transporter compositions for facilitating the engraftment of histo-incompatible bone marrow and controlling the immune reactions in the recipient host
US5240909B1 (en) * 1990-03-14 1998-01-20 Dietrich Nitsche Use of lactoferrin for treatment of toxic effects of endotoxins
CA2128111C (en) * 1992-01-15 1998-06-16 Klaas Daniel Kussendrager Process for isolating lactoferrin and lactoperoxidase from milk and milk products, and products obtained by such process
JP3100005B2 (ja) * 1992-07-28 2000-10-16 雪印乳業株式会社 ヒト免疫不全ウィルス感染・増殖抑制剤
JP3112637B2 (ja) * 1994-09-30 2000-11-27 雪印乳業株式会社 骨強化剤
JP2974604B2 (ja) 1996-01-23 1999-11-10 雪印乳業株式会社 塩基性タンパク質組成物、塩基性ペプチド組成物及びその利用
JP2001504447A (ja) * 1996-08-12 2001-04-03 エイプラス サイエンス インベスト アーベー ラクトフェリンおよび／またはラクトフェリシンでの、感染、炎症および／または腫瘍の処置および予防
JPH1059864A (ja) * 1996-08-15 1998-03-03 Morinaga Milk Ind Co Ltd 経口がん転移抑制剤
US6440446B1 (en) * 1998-04-22 2002-08-27 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Agent for anti-osteoporosis
US6251860B1 (en) * 1998-07-07 2001-06-26 Suomen Punainen Risti Veripalvelu Pharmaceutical preparations
CN1195544C (zh) * 1998-07-30 2005-04-06 森永乳业株式会社 用于慢性肝炎的肝功能改善剂
US6258383B1 (en) * 1998-08-14 2001-07-10 Lactoferrin Products Company Dietary supplement combining colostrum and lactoferrin in a mucosal delivery format
JP3739589B2 (ja) 1999-03-31 2006-01-25 雪印乳業株式会社 骨強化剤
US6251560B1 (en) * 2000-05-05 2001-06-26 International Business Machines Corporation Photoresist compositions with cyclic olefin polymers having lactone moiety
AU2002230997A1 (en) * 2000-12-15 2002-06-24 Genetics Institute, Llc Methods and compositions for diagnosing and treating rheumatoid arthritis
US20030191193A1 (en) * 2002-04-03 2003-10-09 Jillian Cornish Lactoferrin

Also Published As

Publication number Publication date
EP1490404B1 (en) 2013-08-21
US20100305308A1 (en) 2010-12-02
US20030191193A1 (en) 2003-10-09
US20080188644A1 (en) 2008-08-07
US20090259025A1 (en) 2009-10-15
JP4327607B2 (ja) 2009-09-09
US20110183008A1 (en) 2011-07-28
ES2435071T3 (es) 2013-12-18
PT1490404E (pt) 2013-09-24
CA2481315A1 (en) 2003-10-09
WO2003082921A1 (en) 2003-10-09
CN1625566B (zh) 2012-10-10
EP1490404A1 (en) 2004-12-29
EP1490404A4 (en) 2010-02-24
AR040695A1 (es) 2005-04-13
CN1625566A (zh) 2005-06-08
AU2002324387A1 (en) 2003-10-13
JP2006501143A (ja) 2006-01-12
DK1490404T3 (da) 2013-09-16
HK1074635A1 (en) 2005-11-18
US8703699B2 (en) 2014-04-22
KR20050006140A (ko) 2005-01-15

Similar Documents

Publication Publication Date Title
BR0215682A (pt) Lactoferrina
DE69428791D1 (de) Verwendung vonModafinil zur Behandlung von Atemstillstand im Schlaf und zentral erregten Atembeschwerden
BR9814814A (pt) Processos para modular função de quinase de proteìna serina/treonina com compostos à base de 5-azaquinoxalina
DE69433530D1 (de) Bmp-11 zusammensetzungen
BR9814984A (pt) Processos para tratar condições fìsicas resultantes do declìnio pós-menopáusico de estrogênio em uma paciente pós-menopáusica e para reduzir o risco de fraturas ósseas osteoporóticas em uma paciente, e, conjunto para uso por uma comsumidora atormentada com, ou suscetìvel a, condições fìsicas resultantes do declìnio pós-menopáusico de estrogênio
BRPI9915679A8 (pt) Composições e métodos para aumentar a mineralização óssea
DE60228084D1 (de) System zur Fixierung von Knochenfrakturen
BG102619A (en) Substituted n-[(aminoiminomethyl or aminomethyl) phenyl] propylamides
ATE300305T1 (de) Verwendung von cytidin und cytosin-enthaltenden verbindungen zur behandlung von reizmittelgelgebrauch
PT1028744E (pt) Utilizcoes neuronais de bmp-11
BR9911917A (pt) Composições compreendendo análogos de gaba e cafeìna
BRPI0415781A (pt) método para o tratamento de diabetes em um paciente e kit farmacêutico
BR0212757A (pt) Composição, método para produzir uma composição de fator de crescimento, e, método para tratar um defeito de osso, tendão ou cartilagem
BR9914848A (pt) Composição e processo para o tratamento de distúrbios da retina externa
DE60143818D1 (de) Alpha-fetoprotein-peptide und ihre verwendung
BR9811643A (pt) Suplementação quìmica de osso
AU2003251729A1 (en) Use of antibodies against flt-1 for the treatment of osteoporosis
ATE288498T1 (de) Methoden zur inhibierung von helicobacter pylori
BR0209144A (pt) Composição associadas ao fator de crescimento de fibroblasto humano
ATE245438T1 (de) Verwendung von oligomerem matrixprotein aus knorpel zur behandlung von rheumatoider arthritis
PT910398E (pt) Metodo de estimulacao de cilios
BR9915537A (pt) Gene prv-1 e sua utilização
CO5150204A1 (es) Metodo de aumentar el volumen oseo que comprende la administracion de un agonista fp selectivo que no ocurre naturalmente y un agonista ep1 selectivo que no ocurre naturalmente a un sujeto que requiere tal tratamiento
DE69909395D1 (de) Zusammensetzung mit ketanserin und carnitin zur behandlung von crps
PT1401871E (pt) Moleculas de ligacao imunologicas que inibem a fusao sincicial de celulas do tropoblasto

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A(S) 6A,7A E 8A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2108 DE 31/05/2011.